rs267608671
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP2PP3PP5_Very_Strong
The NM_007055.4(POLR3A):c.2554A>G(p.Met852Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,726 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_007055.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152054Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251480Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135912
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461672Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727156
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152054Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74268
ClinVar
Submissions by phenotype
Leukoencephalopathy, ataxia, hypodontia, hypomyelination syndrome Pathogenic:3Other:1
This missense variant (c.2554A>G, p.Met852Val) has been observed at extremely low frequency in population databases (gnomAD) and has been reported in the literature (PMID 21855841, PMID 32600288). Variant prediction programs suggest a deleterious effect, although no functional studies have been published. This change was found to occur in an affected individual who has another likely pathogenic variant (c.1301dupA, p.Tyr434*), and in an unrelated carrier parent of a deceased affected patient. -
- -
- -
The missense c.2554A>G (p.Met852Val) variant in POLR3A gene has been reported in compound heterozygous state in multiple individuals affected with Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (Choquet K et al. 2019; Terao Y et al. 2012; Bernard G et al. 2011). The p.Met852Val variant has allele frequency 0.0008% in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant has been reported to the ClinVar database as Pthogenic / Likely Pathogenic. The amino acid change p.Met852Val in POLR3A is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Met at position 852 is changed to a Val changing protein sequence and it might alter its composition and physico-chemical properties. Functional studies are required to prove the pathogenicity for the variant, for these reasons, this variant has been classified as Likely Pthogenic. -
not provided Pathogenic:2
The M852V variant in the POLR3A gene has been reported previously in several individuals with leukodystrophy, hypogonadotropic hypogonadism, and dental anomalies (Bernard et al., 2011; Terao et al., 2012; Daoud et al., 2013; Wolf et al., 2014). This variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common variant in these populations. The M852V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. The M852V variant is a strong candidate for a pathogenic variant. -
This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 852 of the POLR3A protein (p.Met852Val). This variant is present in population databases (rs267608671, gnomAD 0.006%). This missense change has been observed in individuals with POLR3A-related conditions (PMID: 21855841, 25339210). ClinVar contains an entry for this variant (Variation ID: 31145). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt POLR3A protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects POLR3A function (PMID: 30898877). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Leukodystrophy Pathogenic:1
The p.Met852Val variant in POLR3A has been reported in >10 individuals with POLR3A-related disorders (PMID: 21855841, 32600288, 23355746, 33190326, 29700822, 33652360, 22819058, 34296356, 25339210), and has been identified in 0.005% (1/18392) of East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP: rs267608671). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID: 31145) and has been interpreted as pathogenic by OMIM and GeneReviews and as likely pathogenic by GeneDx. Of the many affected individuals, 1 of those was a homozygote, 2 were compound heterozygotes that carried a reported likely pathogenic variant with unknown phase, and 2 were compound heterozygotes that carried variants of unknown significance in trans, which increases the likelihood that the p.Met852Val variant is pathogenic (Variation ID: 31146, 445922, 31147; PMID: 21855841, 33190326, 34296356). In vitro functional studies provide some evidence that the p.Met852Val variant may impact protein function (PMID: 30898877). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. The p.Met852Val variant is located in a region of POLR3A that is essential to protein folding and stability, suggesting that this variant is in a functional domain and slightly supports pathogenicity (PMID: 21855841). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive POLR3A-related disorders. ACMG/AMP Criteria applied: PM3_strong, PS3, PM1_supporting, PM2_supporting (Richards 2015). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at